2-methyl-5-ht has been researched along with Bradyarrhythmia in 6 studies
2-methyl-5-HT: M-receptor agonist
| Excerpt | Relevance | Reference |
|---|---|---|
| " All three PDE4 inhibitors were administered at 1, 10, or 100 microg/kg (iv) 15 min prior to the induction of bradycardia by an iv injection of 2-methyl-5-HT (von Bezold-Jarisch reflex) or by vagal electrical stimulation." | 3.70 | Selective potentiating effect of RS14203 on a serotoninergic pathway in anesthetized rats. ( Chan, CC; Robichaud, A; Rodger, IW; Savoie, C, 2000) |
| ") dosing to rats." | 1.29 | Pharmacological characterization of FK1052, a dihydropyridoindole derivative, as a new serotonin 3 and 4 dual receptor antagonist. ( Kadowaki, M; Kohsaka, M; Mori, J; Nagakura, Y; Tokoro, K; Tomoi, M, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Delgado, M | 1 |
| Caicoya, AG | 1 |
| Greciano, V | 1 |
| Benhamú, B | 1 |
| López-Rodríguez, ML | 1 |
| Fernández-Alfonso, MS | 1 |
| Pozo, MA | 1 |
| Manzanares, J | 1 |
| Fuentes, JA | 1 |
| Eglen, RM | 1 |
| Lee, CH | 1 |
| Smith, WL | 1 |
| Johnson, LG | 1 |
| Clark, R | 1 |
| Whiting, RL | 1 |
| Hegde, SS | 1 |
| Nagakura, Y | 1 |
| Kadowaki, M | 1 |
| Tokoro, K | 1 |
| Tomoi, M | 1 |
| Mori, J | 1 |
| Kohsaka, M | 1 |
| Callera, JC | 2 |
| Sévoz, C | 1 |
| Laguzzi, R | 2 |
| Machado, BH | 2 |
| Savoie, C | 1 |
| Chan, CC | 1 |
| Rodger, IW | 1 |
| Robichaud, A | 1 |
| Leal, DM | 1 |
| Bonagamba, LG | 1 |
| Nosjean, A | 1 |
6 other studies available for 2-methyl-5-ht and Bradyarrhythmia
| Article | Year |
|---|---|
Anxiolytic-like effect of a serotonergic ligand with high affinity for 5-HT1A, 5-HT2A and 5-HT3 receptors.
Topics: 3,4-Dihydroxyphenylacetic Acid; 8-Hydroxy-2-(di-n-propylamino)tetralin; Adenylyl Cyclase Inhibitors; | 2005 |
Pharmacological characterization of RS 25259-197, a novel and selective 5-HT3 receptor antagonist, in vivo.
Topics: Administration, Oral; Animals; Bradycardia; Dogs; Dose-Response Relationship, Drug; Duodenum; Female | 1995 |
Pharmacological characterization of FK1052, a dihydropyridoindole derivative, as a new serotonin 3 and 4 dual receptor antagonist.
Topics: 5-Methoxytryptamine; Acetylcholine; Animals; Bradycardia; Electric Stimulation; Guinea Pigs; Histami | 1993 |
Microinjection of a serotonin3 receptor agonist into the NTS of unanesthetized rats inhibits the bradycardia evoked by activation of the baro- and chemoreflexes.
Topics: Animals; Blood Pressure; Bradycardia; Chemoreceptor Cells; Heart Rate; Male; Microinjections; Presso | 1997 |
Selective potentiating effect of RS14203 on a serotoninergic pathway in anesthetized rats.
Topics: Afferent Pathways; Animals; Bradycardia; Efferent Pathways; Electric Stimulation; Heart Rate; Male; | 2000 |
Microinjection of a 5-HT3 receptor agonist into the NTS of awake rats inhibits the bradycardic response to activation of the von Bezold-Jarisch reflex.
Topics: Analysis of Variance; Animals; Arousal; Blood Pressure; Bradycardia; Heart Rate; Male; Microinjectio | 2001 |